David G. Mutch

ORCID: 0000-0002-6921-1581 · 6 papers in corpus
article 2024
·doi:10.1158/1557-3265.endo24-pr003

Abstract Obesity is a major risk factor for endometrial cancer (EC), and glucagon like peptide-1 receptor (GLP-1R) agonists such as semaglutide may be helpful to achieve weight loss during conservative treatment or for EC prevention. Proges…

2023
Journal of gynecologic oncology ·doi:10.3802/jgo.2023.34.e85

IntroductionMany advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now ava…

preprint 2023
·doi:10.1158/1078-0432.22452648.v1

PDF file - 1049K, Supplementary Figure S1. Summarized sequencing reads and coverage of MBDCap-seq Supplementary Figure S2. Reproducibility test of MBDCap-seq Supplementary Figure S3. Validation of MBDCap-seq by MassARRAY analysis Supplement…

preprint 2023
·doi:10.1158/1078-0432.22452648

PDF file - 1049K, Supplementary Figure S1. Summarized sequencing reads and coverage of MBDCap-seq Supplementary Figure S2. Reproducibility test of MBDCap-seq Supplementary Figure S3. Validation of MBDCap-seq by MassARRAY analysis Supplement…

2017
Gynecologic oncology reports ·doi:10.1016/j.gore.2017.09.002

BackgroundMayer-Rokitansky-Küster-Hauser syndrome is a rare entity with proposed genetic underpinnings. Ovarian carcinoma has well-described genetic associations and syndromes, although much of the etiology of the disease remains unknown.Ca…

article 2013
·doi:10.1158/1538-7445.am2013-1378

Abstract Objective: To investigate the potential factors associated with survival in gynecologic oncology patients diagnosed with intestinal perforation and pneumatosis intestinalis. Methods: A retrospective chart review was performed of al…